Crossing APP23 transgenic mice with ob/ob (leptin deficient) mice resulted in enhanced diabetes symptoms (blood glucose levels and plasma insulin) compared to ob/ob mice alone, but with reduced insulin levels in the brain. This evidence concerns the gene INS and diabetes mellitus.